A Revolution in The Biopharmaceuticals Market- Global Opportunity Analysis And Industry Forecast, 2018-2025

The global biopharmaceuticals market is driven by various factors, such as increase in elderly population, surge in prevalence of chronic diseases such as cancer and diabetes, and increase in adoption of biopharmaceuticals globally. Furthermore, rise in strategic collaborations among biopharmaceuticals companies is also anticipated to supplement the growth of the biopharmaceuticals industry.

The global biopharmaceuticals market accounted for $186,470 million in 2017, and is projected to reach $526,008 million by 2025, registering a CAGR of 13.8% from 2018 to 2025. Biopharmaceuticals are substances that are produced using living organisms, such as microorganisms and animal cells, and have a high-therapeutic value. These large and complex molecular drugs are also known as biologics and biotech drugs.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/3971

Biopharmaceuticals, also known as biologics, are drugs that are manufactured in living systems, such as microorganisms and animal cells. An array of different biopharmaceuticals is also produced using recombinant DNA technology. The biopharmaceuticals sector is the fastest-growing segment of the pharmaceutical industry.

The global biopharmaceuticals market is anticipated to grow considerably in the near future, owing to various factors, such as strategic collaborations among biopharmaceuticals companies, increase in obesity and sedentary lifestyle among the population, rise in elderly population, and upsurge in prevalence of chronic diseases, such as cancer, globally. However, high costs associated with biopharmaceuticals drug development and a stringent regulatory scenario are key factors expected to impede the market growth. On the contrary, emerging markets, such as India and China, are anticipated to provide lucrative growth opportunities to the market players during the forecast period.

By type, the monoclonal antibody segment accounted for nearly two-fifths share of the global biopharmaceuticals market in 2017. In terms of application, the oncology segment accounted for one-third share in 2017, and is projected to exhibit a prominent growth rate, owing to surge in cancer prevalence globally. By region, North America generated the highest revenue in the global biopharmaceuticals market in 2017.

North America held the highest market share in 2017, owing to high prevalence rate of cancer and other chronic diseases, adoption of biologics, and increase in awareness about biopharmaceuticals. The Asia-Pacific region is expected to grow at the highest CAGR of 17.2% during the forecast period, owing to rapid industrialization in the area, increase in disposable income, and upsurge in government initiatives to modernize the healthcare infrastructure.

The report provides an extensive competitive analysis and profiles of the key market players, such as

-Abbott Laboratories,
-Amgen, Inc.,
-Biogen, Inc.,
-Eli Lilly and Company,
-F. Hoffmann-La Roche, Ltd.,
-Johnson & Johnson,
-Merck & Co., Inc.,
-Novo Nordisk A/S,
-Pfizer, Inc., and
-Sanofi.

The other players in the value chain (not included in the report) include Bristol Myers Squibb Company, Bayer AG, and Shire plc.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/3971

LIST OF TABLES

TABLE 01. COMPLETED CLINICAL TRIALS IN BIOPHARMACEUTICALS MARKET
TABLE 02. GLOBAL BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 03. KEY MONOCLONAL ANTIBODIES
TABLE 04. MONOCLONAL ANTIBODIES BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 05. INTERFERONS BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 06. INSULIN BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 07. GROWTH AND COAGULATION FACTORS BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 08. ERYTHROPOIETIN BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 09. VACCINES BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 10. HORMONES BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 11. OTHER BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 13. CANCER: KEY BIOPHARMACEUTICALS
TABLE 14. ONCOLOGY BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 15. BLOOD DISORDERS: KEY BIOPHARMACEUTICALS
TABLE 16. BLOOD DISORDERS BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 17. METABOLIC DISEASES BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 18. INFECTIOUS DISEASES BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 19. CARDIOVASCULAR DISEASES BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 20. NEUROLOGICAL DISEASES BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 21. IMMUNOLOGY BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 22. OTHER APPLICATIONS BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 23. BIOPHARMACEUTICALS MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
TABLE 24. NORTH AMERICA BIOPHARMACEUTICALS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 25. U.S. BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 26. U.S. BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 27. CANADA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 28. CANADA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 29. MEXICO BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 30. MEXICO BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 31. NORTH AMERICA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 32. NORTH AMERICA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 33. EUROPE BIOPHARMACEUTICALS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 34. GERMANY BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 35. GERMANY BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 36. FRANCE BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 37. FRANCE BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 38. UK BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 39. UK BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 40. ITALY BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 41. ITALY BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 42. SPAIN BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 43. SPAIN BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 44. REST OF EUROPE BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 45. REST OF EUROPE BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 46. EUROPE BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 47. EUROPE BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 48. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 49. JAPAN BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 50. JAPAN BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 51. CHINA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 52. CHINA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 53. INDIA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 54. INDIA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 55. AUSTRALIA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 56. AUSTRALIA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 57. SOUTH KOREA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 58. SOUTH KOREA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 59. REST OF ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 60. REST OF ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 61. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 62. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 63. LAMEA BIOPHARMACEUTICALS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 64. BRAZIL. BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 65. BRAZIL BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 66. SAUDI ARABIA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 67. SAUDI ARABIA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 68. SOUTH AFRICA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 69. SOUTH AFRICA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 70. REST OF LAMEA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 71. REST OF LAMEA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 72. LAMEA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 73. LAMEA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 74. ABBOTT: COMPANY SNAPSHOT
TABLE 75. ABBOTT: OPERATING SEGMENTS
TABLE 76. ABBOTT: PRODUCT PORTFOLIO
TABLE 77. AMGEN: COMPANY SNAPSHOT
TABLE 78. AMGEN: PRODUCT PORTFOLIO
TABLE 79. BIOGEN: COMPANY SNAPSHOT
TABLE 80. BIOGEN: PRODUCT PORTFOLIO
TABLE 81. LILLY: COMPANY SNAPSHOT
TABLE 82. LILLY: OPERATING SEGMENTS
TABLE 83. LILLY: PRODUCT PORTFOLIO
TABLE 84. ROCHE: COMPANY SNAPSHOT
TABLE 85. ROCHE: OPERATING SEGMENTS
TABLE 86. ROCHE: PRODUCT PORTFOLIO
TABLE 87. J&J: COMPANY SNAPSHOT
TABLE 88. J&J: OPERATING SEGMENTS
TABLE 89. J&J: PRODUCT PORTFOLIO
TABLE 90. MERCK: COMPANY SNAPSHOT
TABLE 91. MERCK: OPERATING SEGMENTS
TABLE 92. MERCK: PRODUCT PORTFOLIO
TABLE 93. NOVO NORDISK: COMPANY SNAPSHOT
TABLE 94. NOVO NORDISK: OPERATING SEGMENTS
TABLE 95. NOVO NORDISK: PRODUCT PORTFOLIO
TABLE 96. PFIZER: COMPANY SNAPSHOT
TABLE 97. PFIZER: OPERATING SEGMENTS
TABLE 98. PFIZER: PRODUCT PORTFOLIO
TABLE 99. SANOFI: COMPANY SNAPSHOT
TABLE 100. SANOFI: OPERATING SEGMENTS
TABLE 101. SANOFI: PRODUCT PORTFOLIO

Access Full Summery @ https://www.alliedmarketresearch.com/biopharmaceutical-market

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.